We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Immupharma Plc | LSE:IMM | London | Ordinary Share | GB0033711010 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 2.14 | 2.10 | 2.18 | 2.20 | 2.19 | 2.19 | 604,698 | 16:35:15 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Finance Services | 0 | -3.81M | -0.0114 | -1.93 | 7.33M |
TIDMIMM
RNS Number : 3973M
Immupharma PLC
06 May 2015
6 MAY 2015
ImmuPharma
ANNUAL REPORT AND ACCOUNTS
NOTICE OF ANNUAL GENERAL MEETING: 29 MAY 2015
ImmuPharma PLC (LSE:IMM), ("ImmuPharma" or the "Company"), the specialist drug discovery and development company confirms that the Annual Report and Accounts for the year ended 31 December 2014 will be posted to shareholders today.
The Annual Report will be available later today, in electronic form, for download on the Company's website www.immupharma.org.
The Company's Annual General Meeting will be held on Friday 29 May 2015 at 11:00am at the offices of Bircham Dyson Bell LLP, 50 Broadway, London, SW1H 0BL.
For further information please contact:
+ 44 (0) 20 ImmuPharma plc 7152 4080 Dimitri Dimitriou, Chief Executive Officer Dr Robert Zimmer, President and Chief Scientific Officer Franco di Muzio, Interim Chairman Tracy Weimar, Vice President, Operations and Finance Lisa Baderoon, Head of Investor + 44 (0) 7721 Relations 413496 Panmure Gordon (UK) Limited, NOMAD +44 (0) 20 & Broker 7886 2500 Hugh Morgan, Fred Walsh, Duncan Monteith, Corporate Finance Charles Leigh-Pemberton, Corporate Broking
This information is provided by RNS
The company news service from the London Stock Exchange
END
ACSUGUPCAUPAGCQ
1 Year Immupharma Chart |
1 Month Immupharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions